Valuation Longevity Health Holdings, Inc.
Equities
XAGE
US1429221294
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3400 USD | +32.45% |
|
+13.33% | +12.99% |
Company Valuation: Longevity Health Holdings, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Capitalization 1 | - | - | 87.94 | 5.835 | 0.5361 |
| Change | - | - | - | -93.37% | -90.81% |
| Enterprise Value (EV) 1 | - | - | 87.17 | 6.317 | 0.3293 |
| Change | - | - | - | -92.75% | -94.79% |
| P/E ratio | -32.8x | -29.5x | -2.6x | -0.58x | -0.06x |
| PBR | -12x | -3.81x | 3.55x | -1.24x | -0.09x |
| PEG | - | -2x | -0x | 0x | 0x |
| Capitalization / Revenue | - | - | - | 115,956,457x | 280,281x |
| EV / Revenue | - | - | - | - | - |
| EV / EBITDA | - | - | -17x | -1.29x | -0.05x |
| EV / EBIT | - | - | -16.7x | -1.26x | -0.05x |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -8.799 | -10.1 | -43.88 | -14.56 | -4.83 |
| Distribution rate | - | - | - | - | - |
| Net sales | - | - | - | 0.0503 | 1.913 |
| EBITDA 1 | -1.846 | -5.413 | -5.12 | -4.915 | -6.68 |
| EBIT 1 | -1.94 | -5.508 | -5.217 | -4.998 | -6.758 |
| Net income 1 | -6.479 | -9.051 | -15.45 | -10.37 | -6.905 |
| Net Debt 1 | 9.674 | 3.607 | -0.776 | 0.4819 | -0.2069 |
| Reference price 2 | 288.6003 | 297.5193 | 114.3001 | 8.3730 | 0.3009 |
| Nbr of stocks (in thousands) | - | - | 769 | 697 | 1,782 |
| Announcement Date | 2/14/23 | 5/5/23 | 4/1/24 | 3/31/25 | 3/31/26 |
1USD in Million2USD
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 842K | |
| 32.43x | 8.43x | 25.48x | 0.06% | 55.01B | |
| 15.98x | 4.88x | 10.61x | 1.86% | 43.37B | |
| -17.36x | 3.95x | -6.9x | -.--% | 22.27B | |
| -35.24x | 11.68x | -33.72x | -.--% | 20.42B | |
| 21.35x | 4.19x | 10.89x | -.--% | 17.27B | |
| 21.02x | 4.23x | 13.99x | -.--% | 15.02B | |
| 16.69x | 4.81x | 11.27x | -.--% | 13.25B | |
| -410.69x | 27.93x | -3113.74x | -.--% | 11.71B | |
| -13.05x | 3397.02x | -15.86x | -.--% | 11.46B | |
| Average | -40.99x | 385.24x | -344.22x | 0.21% | 20.98B | |
| Weighted average by Cap. | -12.78x | 192.93x | -167.18x | 0.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- XAGE Stock
- Valuation Longevity Health Holdings, Inc.
Select your edition
All financial news and data tailored to specific country editions
